R Mark Ghobrial
Overview
Explore the profile of R Mark Ghobrial including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
2058
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kodali S, Kulik L, DAllessio A, De Martin E, Hakeem A, Lewinska M, et al.
Liver Transpl
. 2025 Feb;
PMID: 40014003
Background: Liver transplantation (LT) provides the best long-term survival outcomes for patients with liver cancer. As a result, the field of transplant oncology has grown greatly over the past few...
2.
Semaan S, Connor A, Saharia A, Kodali S, Elaileh A, Patel K, et al.
Transplant Proc
. 2025 Feb;
57(2):255-263.
PMID: 39939239
Background: Cholangiocarcinoma (CCA) has rising incidence and mortality rates. Outcomes from combination systemic, loco-regional therapy (LRT) and liver transplantation (LT) are improving, but more granular data are needed to inform...
3.
Soliman N, Connor A, Saharia A, Kodali S, Elaileh A, Patel K, et al.
Transplant Direct
. 2025 Feb;
11(3):e1760.
PMID: 39936132
Background: Perihilar cholangiocarcinoma (phCCA) has excellent outcomes following liver transplantation (LT). Neoadjuvant radiation-based locoregional therapy is standard-of-care. Gemcitabine and cisplatin (gem/cis) combination systemic therapies have improved outcomes in advanced settings,...
4.
Hassanain H, Connor A, Brombosz E, Patel K, Elaileh A, Basra T, et al.
Transplant Direct
. 2025 Jan;
11(2):e1746.
PMID: 39866680
Background: Hepatocellular carcinoma (HCC) has a rising incidence and mortality in North America. Liver transplantation (LT) with adjunctive therapies offers excellent outcomes. However, HCC recurrences are associated with high mortality....
5.
Kudo M, Ren Z, Guo Y, Han G, Lin H, Zheng J, et al.
Lancet
. 2025 Jan;
405(10474):203-215.
PMID: 39798578
Background: Transarterial chemoembolisation (TACE) is standard care for unresectable, non-metastatic hepatocellular carcinoma. We aimed to evaluate the addition of lenvatinib and pembrolizumab to TACE versus dual placebo plus TACE in...
6.
Bachini M, Ghobrial R
Curr Opin Organ Transplant
. 2024 Dec;
30(1):1-2.
PMID: 39711241
No abstract available.
7.
Brombosz E, Hobeika M, Kodali S, Connor A, Saharia A, Mobley C, et al.
Transplant Proc
. 2024 Dec;
56(10):2203-2212.
PMID: 39617682
Background: The deceased donor shortage in the United States has led to increased utilization extended criteria donor (ECD) liver grafts. Centers often utilize ECD grafts in patients with low Model...
8.
Cheah Y, Yang H, Simon C, Akoad M, Connor A, Daskalaki D, et al.
Liver Transpl
. 2024 Oct;
31(2):190-200.
PMID: 39441028
Robotic surgery is an emerging minimally invasive option for living donor hepatectomy. Currently, there are no studies on the learning curve of robotic donor hepatectomy. Thus, we evaluated the learning...
9.
Dukewich M, Dodge J, Lucey M, Rice J, Shetty K, Jakhete N, et al.
Am J Gastroenterol
. 2024 Jul;
PMID: 38994850
Introduction: Early (i.e., without mandated period of abstinence) liver transplant (LT) for alcohol-associated hepatitis is the fastest-growing indication for LT in the United States and Europe. Harmful alcohol use after...
10.
Kodali S, Connor A, Brombosz E, Ghobrial R
Gastroenterol Hepatol (N Y)
. 2024 Apr;
20(3):151-158.
PMID: 38680168
Cholangiocarcinoma (CCA) is a neoplasm of the biliary tract that has become increasingly prevalent throughout the world. Common risk factors for developing CCA include cirrhosis, primary sclerosing cholangitis, and trematode...